Total quantity or scope of tender
This challenge is reacting to an unprecedented global pandemic. A rapid Phase 1 SBRI will identify solutions for further development. Subsequent activity will support selected solutions through next phases and explore the potential to expand the scope of the challenge to other areas of training need across the NHS.
We are looking to identify and demonstrate rapid simulation technology solutions in an operational environment, solutions must be suitable for rapid deployment and for successful solutions we envisage full accreditation to be in place ready for ‘real world’ deployment by no later than October 2021.
As an example of the way in which the use of simulation training could be expanded following the competition, the Critical Care team has identified common procedures and scenarios they would prioritise once this capability is available to them.
A successful outcome would:
• Deliver Tracheostomy training in an appropriate safe way.
• Make the training experience as close as possible to the bedside experience, providing a real sense of the actual environment.
• Reduce the need for face-to-face training.
• Deliver training in a more convenient method, without time or location restrictions, increasing numbers being trained and reducing any backlogs.
• Enable consistency of training provided across all Health Boards, including the recording, review and analysis of training procedures
• Enable the clinician to maintain clinical competencies and any revalidation requirements.
• Have a wider applicability to address similar issues in other specialities.
• Ensure patient safety was maintained through providing relevant training to clinicians.
• Generate opportunities for local businesses (e.g. creative industry sector)
• Support place based economic development and local wealth building in the CCR
• Result in innovative new products and services which have a pathway to rapid scaling commercially beyond local markets
Innovations must be suitable for rapid deployment in Tracheostomy Training for Phase 1 and any solution must have wider applicability to other clinical settings.
We need ideas that can be rapidly developed and tested with potential to be scaled and used across Wales and beyond over the coming months.
|